73 related articles for article (PubMed ID: 10953354)
1. Engineering and characterization of a single-chain antibody fragment (scFV1924) against the human sarcoma-associated antigen p102.
Chen H; Wang P; Das Gupta TK
Anticancer Res; 2000; 20(4):2753-60. PubMed ID: 10953354
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and primary characterization of a single-chain antibody against human sarcoma-associated antigen p200.
Chen H; Wang P; Stastny JJ; Shilkaitis A; Liao X; Das Gupta TK
Anticancer Res; 1996; 16(6B):3551-6. PubMed ID: 9042220
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody characterization of sarcoma-associated antigen p102.
Brown JM; Stastny JJ; Beattie CW; Das Gupta TK
Anticancer Res; 1991; 11(4):1565-70. PubMed ID: 1746915
[TBL] [Abstract][Full Text] [Related]
4. Expression of sarcoma-associated antigens p102 and p200 in human sarcoma cell lines.
Song S; Stastny JJ; Chen H; Das Gupta TD
Anticancer Res; 1996; 16(3A):1171-5. PubMed ID: 8702231
[TBL] [Abstract][Full Text] [Related]
5. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11.
Chen D; Shou C
Biochem Biophys Res Commun; 2001 Jan; 280(1):99-103. PubMed ID: 11162484
[TBL] [Abstract][Full Text] [Related]
7. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
[TBL] [Abstract][Full Text] [Related]
8. Construction, expression and characterization of the engineered antibody against tumor surface antigen, p185(c-erbB-2).
Cheng LS; Liu AP; Yang JH; Dong YQ; Li LW; Wang J; Wang CC; Liu J
Cell Res; 2003 Feb; 13(1):35-48. PubMed ID: 12643348
[TBL] [Abstract][Full Text] [Related]
9. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.
Elrick LJ; Leel V; Blaylock MG; Duncan L; Drever MR; Strachan G; Charlton KA; Koruth M; Porter AJ; Wright MC
J Hepatol; 2005 Jun; 42(6):888-96. PubMed ID: 15885360
[TBL] [Abstract][Full Text] [Related]
10. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
11. The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4.
Shoji M; Kawamoto S; Setoguchi Y; Mochizuki K; Honjoh T; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K
Hum Antibodies Hybridomas; 1994; 5(3-4):123-30. PubMed ID: 7756577
[TBL] [Abstract][Full Text] [Related]
12. Cloning and sequencing of variable region cDNAs of a novel human monoclonal antibody to carcinoembryonic antigen, and generation of a single chain variable fragmented antibody.
Shibaguchi H; Kuroki M; Kuroki M; Badran A; Hachimine K; Kinugasa T
Anticancer Res; 2004; 24(5C):3355-60. PubMed ID: 15515431
[TBL] [Abstract][Full Text] [Related]
13. [Construction and expression of single-chain Fv antibody against human VEGF].
Wang D; Yang X; Yuan Q
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):526-9. PubMed ID: 11798812
[TBL] [Abstract][Full Text] [Related]
14. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
15. Preparation of genetically engineered monoclonal antibodies for human immunotherapy.
Parren PW
Hum Antibodies Hybridomas; 1992 Jul; 3(3):137-45. PubMed ID: 1391663
[TBL] [Abstract][Full Text] [Related]
16. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
18. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
19. Cloning, isolation and characterization of human tumor in situ monoclonal antibodies.
Wu H; Pancook JD; Beuerlein G; Chilton T; Pecht G; Huse WD; Watkins JD
Cancer Immunol Immunother; 2002 Apr; 51(2):79-90. PubMed ID: 11904732
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of an active single-chain variable fragment antibody recognizing CD25.
Muramatsu H; Yoshikawa K; Hayashi T; Takasu S; Kawada Y; Uchida K; Sato S; Takahashi T; Saga S; Ueda R
Cancer Lett; 2005 Jul; 225(2):225-36. PubMed ID: 15978327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
